Company
Genevi Technologies
Reimagining urinary incontinence at the source
Also known as Genevi
- Status
- Operatingas of 2026-09-18
Claim, correct or request removal
Record updated 28 September 2026
About
1 in 2 women live with urinary incontinence; yet fewer than 1 in 3 ever seek treatment. Genevi treats the Urethra, the true cause, not just the symptom.
Funding snapshot
- Total raised
- $250KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $250K2024-10-30
Funding rounds
- Round, 2024
- $250K2024-10-30, SEC form D sold, 1 investor
Loading relationship preview